This trend was maintained in primary (CD127+132−: 40% naive, CD127+132+: 43%, CD127−132+:6%; p<0.0001) and chronic HIV infection (CD127+132−: 27% naive, CD127+132+: 27%, CD127−132+:3%; p<0.001; Figure 1a)vi and b)vi). Here, IL7R is linked to HIV infectious disease.